| Literature DB >> 16625409 |
M J Bratby1, E D Lehmann, J Bottomley, D O Kessel, A A Nicholson, S J McPherson, R A Morgan, A-M Belli.
Abstract
We report the application of the liquid embolic agent ethylene-vinyl alcohol (Onyx; MicroTherapeutics, Irvine, CA, USA) in the management of visceral artery aneurysms. The technique and indications for using Onyx are discussed with emphasis on the management of wide-necked aneurysms and maintenance of patency of the parent vessel. None of the cases was considered suitable for stent-grafting or embolization with conventional agents. Two aneurysms of the renal artery bifurcation and one aneurysm of the inferior pancreaticoduodenal artery were treated. Following treatment there was complete exclusion of all aneurysms. There was no evidence of end-organ infarction. Follow-up with intervals up to 6 months has shown sustained aneurysm exclusion. Onyx is known to be effective in the management of intracranial aneurysms. Our experience demonstrates the efficacy and applicability of the use of Onyx in the treatment of complex visceral artery aneurysms.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16625409 DOI: 10.1007/s00270-005-0148-3
Source DB: PubMed Journal: Cardiovasc Intervent Radiol ISSN: 0174-1551 Impact factor: 2.740